StocksFin Logo
NVS logo
$NVS

Novartis AG

NVS country of incorporation
|
https://www.novartis.com
|
Joseph Jimenez
|
108,000 employees
NYSE | Healthcare | Drug Manufacturers—General
NVS reported its Q322 earnings on September 30, 2022 (103 weeks ago).
$12.84B -3.9% vs. Q321 Revenues Q322
70.36% -0.3% vs. Q321 Gross Profit Margin
12.25% -40.6% vs. Q321 Net Profit Margin
4.14B -5.6% vs. Q321 Free Cash Flow Q322
$0.73 -40.7% vs. Q321 EPS Q322
Company Card Q322
As reported on September 30, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B-
Growth calculated YoY
Company Card Q322
As reported on September 30, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B-
Growth calculated YoY
Overview
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
12.84B
-1.9%
3.81B
1.57B
-7.1%
$0.73
Q22022
13.09B
+2.1%
3.75B
1.69B
-23.8%
$0.77
Q12022
12.81B
3.86B
2.22B
$1
FY2021
52.88B
 15.87B
24.02B
$10
Q42021
13.52B
+1.2%
3.98B
16.31B
+491.3%
$7.29
Q32021
13.37B
+0.5%
3.94B
2.76B
-4.8%
$1.23
Q22021
13.29B
+4.7%
3.91B
2.9B
+40.7%
$1.29
Q12021
12.69B
4.04B
2.06B
$0.91
FY2020
49.9B
 15.12B
8.07B
$3.55
FY2019
48.68B
 14.43B
11.73B
$5.12
FY2018
53.17B
 18.41B
12.61B
$5.44
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
118.46B
 57.57B
8.73B
28.54B
60.82B
Q22022
122.91B
 59.9B
3.63B
31.09B
62.93B
Q12022
125.22B
 63.51B
13.85B
31.34B
61.54B
FY2021
131.8B
 63.97B
12.41B
37.53B
67.66B
FY2020
132.06B
 75.39B
9.66B
45.44B
56.6B
FY2019
118.37B
 62.82B
11.11B
34.05B
55.47B
FY2018
145.56B
 66.87B
13.27B
41.71B
78.61B
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
4.72B
 5.2B
-4.74B
-582M
4.14B
+30.5%
Q22022
3.76B
 -11.63B
-2.3B
-583M
3.17B
+301.5%
Q12022
1.65B
 9.37B
-9.53B
-859M
790M
FY2021
15.07B
 4.21B
-16.26B
-2.97B
12.1B
FY2020
13.65B
 -13.18B
-2.21B
-2.59B
11.07B
FY2019
13.63B
 -2.23B
-13.63B
-2.26B
11.37B
FY2018
14.27B
 -5.59B
-4.24B
-3.36B
10.92B
Institutional Ownership
Dividend History
Date Amount
Mar 8, 2022 $2.16
Mar 4, 2021 $3.2
Mar 3, 2020 $3.04
Mar 4, 2019 $2.57
Mar 6, 2018 $2.67
Mar 1, 2017 $2.72
Feb 24, 2016 $2.72
Mar 2, 2015 $2.52
Number of Employees